Kterazone Tablet 50 mg (Tegoprazan)

Adult dose

This medicine is administered to adults as follows. Treatment of erosive gastroesophageal reflux disease: Administer 50 mg orally once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, administer for an additional 4 weeks. Treatment of non-erosive gastroesophageal reflux disease: Administer 50 mg orally once daily for 4 weeks. Treatment of gastric ulcers: Administer 50 mg orally once daily for 8 weeks. Concomitant antibiotic therapy for Helicobacter pylori eradication in patients with peptic ulcer and/or chronic atrophic gastritis: Patients infected with Helicobacter pylori should receive eradication therapy. Administer this medicine 50 mg with amoxicillin 1 g and clarithromycin 500 mg orally twice daily for 7 days. Maintenance treatment after treatment of erosive gastroesophageal reflux disease<25mg only>: Administer 25 mg orally once daily. This medicine may be administered regardless of meals.

This medication should not be used in certain patients. Patients who are allergic to this drug or its components, those taking certain antiviral medications, and pregnant or nursing women should not take this medication. Patients with liver or kidney function problems, as well as the elderly, should use this medication cautiously. During treatment, gastrointestinal issues such as nausea, diarrhea, dyspepsia, as well as neurological symptoms such as headache and dizziness may occur. Additionally, rare symptoms such as skin rash, myalgia, and fatigue may also occur, and any unusual symptoms should be consulted with a physician. Long-term use of this medication may lead to vitamin B12 deficiency, requiring regular check-ups. Care must be taken to ensure gastric ulcers or esophageal diseases are not confused with malignant tumors, and long-term use may increase the risk of gastric polyps or osteoporosis-related fractures. Furthermore, this medication can inhibit gastric acid secretion, increasing the risk of gastrointestinal bacterial infections; if diarrhea persists, medical consultation is necessary. This drug may interact with other medications, so any other medications being taken must be disclosed. It is generally safer not to take this medication during pregnancy or lactation. Safety in children and adolescents has not been established, and elderly patients or those with liver or kidney disorders should be especially cautious. In the case of overdose, no specific treatment is available, so appropriate measures must be taken based on symptoms, and it should be stored out of reach of children.

• Nausea
• diarrhea
• indigestion
• nasopharyngitis
• viral upper respiratory infection
• chest discomfort
• epigastric pain
• abdominal discomfort
• constipation
• abdominal pain

This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. Maintain storage temperature within the range of 1 to 30 degrees Celsius at room temperature to help preserve the drug's effectiveness.

Appearance

Light pink oval film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle